2 Autoimmune Diseases

What autoimmune diseases are

Autoimmune diseases develop when the immune system mistakenly targets the body’s own cells or tissues. They can affect one organ or multiple organ systems, and symptoms may fluctuate between flares and periods of improvement.

More than 80 autoimmune diseases are recognized. Examples include type 1 diabetes, Hashimoto thyroiditis, rheumatoid arthritis, and systemic lupus erythematosus (SLE).

How autoimmunity develops

The immune system normally maintains self-tolerance: it limits immune responses against the body’s own tissues while retaining the ability to respond to infections and other threats. Autoimmunity develops when this control fails.

Self-reactive B cells may produce autoantibodies. Self-reactive T cells can directly injure tissues or stimulate inflammation, and antibodies and immune cells may also work together to damage organs.

Disease risk reflects interactions among genetic susceptibility, immune regulation, and environmental influences. In some susceptible people, an infection or another exposure may contribute to triggering disease, but the cause of a particular person’s illness is often unknown. An autoantibody can be present without clinical disease, so a positive test alone does not establish an autoimmune diagnosis.

Patterns of tissue involvement

Autoimmune diseases are often grouped according to which tissues they affect. An organ-specific disease primarily affects one organ or tissue. In type 1 diabetes, immune-mediated destruction of pancreatic beta cells reduces insulin production. In autoimmune thyroid disease, the thyroid may become underactive, as in Hashimoto thyroiditis, or overactive, as in Graves disease.

A systemic disease can affect several organs. SLE may involve joints, skin, kidneys, blood cells, lungs, or other tissues. Rheumatoid arthritis commonly causes persistent inflammation of the joint lining and may also affect organs beyond the joints.

Symptoms depend on the tissues involved. Inflammation may cause pain, warmth, redness, and swelling; other possible features include fatigue, rashes, muscle weakness, or changes in organ function. Symptoms can overlap with those of infections and many non-autoimmune conditions, so the overall pattern and time course matter.

How autoimmune diseases are diagnosed

Diagnosis combines clinical history, physical examination, and targeted tests. Clinicians consider which organs are affected, how symptoms have changed over time, family history, examination findings, and possible alternative causes.

Depending on the suspected disease, testing may include blood counts, measures of inflammation, organ-function tests, disease-associated antibodies, imaging, or tissue biopsy. No single blood test diagnoses all autoimmune diseases. Some antibody tests are more useful when interpreted alongside a characteristic clinical pattern; a positive result by itself does not prove that disease is present. Conversely, a negative test does not necessarily rule out every autoimmune condition. Evaluation may require follow-up as symptoms and findings evolve.

Treatment and ongoing care

Treatment is tailored to the disease, the organs affected, and disease severity. Common goals are to reduce harmful inflammation, prevent or limit organ damage, relieve symptoms, and preserve function.

Approaches may include:

• Targeted replacement or supportive treatment: Insulin may be used for type 1 diabetes, and thyroid hormone may be used for hypothyroidism.

• Anti-inflammatory or immune-modifying medicines: Corticosteroids and other treatments may be used to control inflammation or suppress specific parts of the immune response.

• Monitoring and supportive care: Regular assessment helps track disease activity, organ function, treatment effects, and complications.

Because immunosuppressive treatment can weaken defenses against infection, clinicians weigh its benefits against risks and monitor for adverse effects. The appropriate plan differs by condition, and treatment should be guided by a qualified health professional.